These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 26074742

  • 1. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R, Mannocchi G, Pantano F, Romolo FS.
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [Abstract] [Full Text] [Related]

  • 2. Toxicology and Analysis of Psychoactive Tryptamines.
    Malaca S, Lo Faro AF, Tamborra A, Pichini S, Busardò FP, Huestis MA.
    Int J Mol Sci; 2020 Dec 04; 21(23):. PubMed ID: 33291798
    [Abstract] [Full Text] [Related]

  • 3. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M.
    Arch Toxicol; 2015 Aug 04; 89(8):1151-73. PubMed ID: 25877327
    [Abstract] [Full Text] [Related]

  • 4. Clinical toxicology of newer recreational drugs.
    Hill SL, Thomas SH.
    Clin Toxicol (Phila); 2011 Oct 04; 49(8):705-19. PubMed ID: 21970769
    [Abstract] [Full Text] [Related]

  • 5. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S, Mosca A, Miuli A, Santovito MC, Orsolini L, Corkery JM, Guirguis A, Pettorruso M, Martinotti G, Di Giannantonio M, Schifano F.
    Medicina (Kaunas); 2021 Jun 06; 57(6):. PubMed ID: 34204131
    [Abstract] [Full Text] [Related]

  • 6. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O.
    Forensic Sci Int; 2014 Oct 06; 243():23-9. PubMed ID: 24726531
    [Abstract] [Full Text] [Related]

  • 7. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ, Martins SS, Su MK, Ompad DC.
    Drug Alcohol Depend; 2015 Nov 01; 156():112-119. PubMed ID: 26377051
    [Abstract] [Full Text] [Related]

  • 8. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M.
    Swiss Med Wkly; 2015 Nov 01; 145():w14043. PubMed ID: 25588018
    [Abstract] [Full Text] [Related]

  • 9. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.
    Rodrigues CHP, Mariotto LS, Castro JS, Peruquetti PH, Silva-Junior NC, Bruni AT.
    Forensic Toxicol; 2023 Jul 01; 41(2):187-212. PubMed ID: 36604359
    [Abstract] [Full Text] [Related]

  • 10. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry.
    Armenta S, Garrigues S, de la Guardia M, Brassier J, Alcalà M, Blanco M, Perez-Alfonso C, Galipienso N.
    Drug Test Anal; 2015 Apr 01; 7(4):280-9. PubMed ID: 24935207
    [Abstract] [Full Text] [Related]

  • 11. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
    Yu WJ, Cottler L, Li JH.
    J Food Drug Anal; 2021 Mar 15; 29(1):168-181. PubMed ID: 35696229
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A, Pragst F, Krumbiegel F, Hartwig S.
    Forensic Sci Int; 2022 Feb 15; 331():111148. PubMed ID: 34923263
    [Abstract] [Full Text] [Related]

  • 13. New Psychoactive Substances: A Matter of Time.
    Pantano F, Graziano S, Pacifici R, Busardò FP, Pichini S.
    Curr Neuropharmacol; 2019 Feb 15; 17(9):818-822. PubMed ID: 31577198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'.
    Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A.
    Ann Agric Environ Med; 2012 Feb 15; 19(4):871-82. PubMed ID: 23311821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
    Liakoni E, Dolder PC, Rentsch KM, Liechti ME.
    BMC Pharmacol Toxicol; 2016 May 26; 17(1):25. PubMed ID: 27228985
    [Abstract] [Full Text] [Related]

  • 19. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC, Weng TI, Ng CJ, Shih CP, Hsu J, Liao YC, Yang CC, Fang CC, TEDAS Research Group.
    Clin Toxicol (Phila); 2022 Jun 26; 60(6):708-715. PubMed ID: 35315299
    [Abstract] [Full Text] [Related]

  • 20. Toxicology and management of novel psychoactive drugs.
    Kersten BP, McLaughlin ME.
    J Pharm Pract; 2015 Feb 26; 28(1):50-65. PubMed ID: 25261428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.